en

PRODUCT DETAIL

KANILAD 200 mg filmom obalené tablety

Code 5898C
MA number 21/0356/17-S
Product Form: tbl flm 14x200 mg (blis.PVC/PVDC/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 21 - ANTIEPILEPTICA, ANTICONVULSIVA
ATC:
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX18 Lacosamide
Shelf life: 36
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 21.11.2017
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_KANILAD_11.2022.pdf  
SPC: SPC_KANILAD_11.2022.pdf  
Safety feature Yes
Data update: 28.03.2022
eu-flag.png sk-flag.png